Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial
European Respiratory Journal · 2025-02 · 65 (2) · 2400733
DOI: 10.1183/13993003.00733-2024 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Respiratory Journal, online erschienen am 05.12.2024. Verfasst von Alberto Benazzo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Lung Transplantation, Photopheresis, Graft Rejection. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mallinckrodt Pharmaceuticals.
Abstract (Originalsprache)
Background
Lung transplant recipients have the worst long-term outcomes of all solid organs due to acute rejection and chronic lung allograft dysfunction (CLAD). Our objective was to investigate the efficacy of extracorporeal photopheresis (ECP) as a prophylactic treatment to prevent acute cellular rejection (ACR), cytomegalovirus (CMV) infections and reduce the risk of CLAD.
Methods
This was a single-centre prospective randomised controlled trial conducted at the Medical University of Vienna (Vienna, Austria) between 2018 and 2020. It included 31 COPD recipients per group. The treatment group underwent ECP in addition to a standard triple-drug immunosuppression protocol after lung transplantation. The control group received standard triple-drug immunosuppressive therapy. The primary outcome was a composite outcome defined as incidence of high-grade ACR, CMV infection or CLAD within 24 months after lung transplantation.
Results
In the control group, 19 patients (61.3%) achieved the primary combined end-point compared with only six patients (19.4%) in the treatment group (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Division of Transplantation, Department of General Surgery, Medical University of Vienna, Vienna, Austria.
- Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
- Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.
- Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria peter.jaksch@meduniwien.ac.at.
ORCID-Profile: Alberto Benazzo, Clemens Aigner, Peter Jaksch
Förderung
- Mallinckrodt Pharmaceuticals
Zitieren
APA
Benazzo, A., Cho, A., Auner, S., Schwarz, S., Kovacs, Z., Ramazanova, D., Kolovratova, V., Branka, M., Muraközy, G., Hielle-Wittmann, E., Aigner, C., Hoetzenecker, K., Wekerle, T., Worel, N., Knobler, R., & Jaksch, P. (2025). Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial. European Respiratory Journal, 65(2), 2400733. https://doi.org/10.1183/13993003.00733-2024
Vancouver
Benazzo A, Cho A, Auner S, Schwarz S, Kovacs Z, Ramazanova D, et al. Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial. European Respiratory Journal. 2025;65(2):2400733. doi:10.1183/13993003.00733-2024
BibTeX
@article{Benazzo2025,
author = {Benazzo, Alberto and Cho, Ara and Auner, Sophia and Schwarz, Stefan and Kovacs, Zsofia and Ramazanova, Dariga and Kolovratova, Vera and Branka, Manuela and Muraközy, Gabriela and Hielle-Wittmann, Elisabeth and Aigner, Clemens and Hoetzenecker, Konrad and Wekerle, Thomas and Worel, Nina and Knobler, Robert and Jaksch, Peter},
title = {Extracorporeal photopheresis for the prevention of rejection after lung transplantation: a prospective randomised controlled trial},
journal = {European Respiratory Journal},
year = {2025},
volume = {65},
number = {2},
pages = {2400733},
doi = {10.1183/13993003.00733-2024}
}
EUVIMED